Published in Vaccine Weekly, August 14th, 1995
Bacterial proteins, called bacteriocins, are produced to prevent the growth of competing microorganisms within a particular biological niche. A preparation of a bacteriocine from the HSC10 strain of E. coli has shown antineoplastic activity in vitro against a variety of human tumor cell lines and also in vivo against Mycosis fungoides skin tumors in humans in many studies.
This preparation of partially purified bacteriocin [or anticancer proteins (ACP)] has also been shown to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly